Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazuhisa Minamiguchi
Observed names:
K Minamiguchi,
K. Minamiguchi,
Kazuhisa G Minamiguchi
Institution:
Taiho Pharmaceutical (Japan)
Observed institutions:
Osaka Prefecture University,
Microbial Chemistry Research Foundation,
Taiho Pharmaceutical (Japan),
The University of Osaka
ORCID:
0009-0007-6801-6614
Observed ORCID:
0009-0007-6801-6614
OpenAlex ID:
A5083062503
Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin
1995
·
H Nagase
, K Enjyoji
, et al.
·
Blood
·
103
Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis
2001
·
Kazuhisa Minamiguchi
, Hiroyuki Kumagai
, et al.
·
International Journal of Cancer
·
71
Dhg, a New Depolymerized Holothurian Glycosaminoglycan, Exerts an Antithrombotic Effect With Less Bleeding Than Unfractionated or Low Molecular Weight Heparin, in Rats
1996
·
Kenji Kitazato
, Keiko T Kitazato
, et al.
·
Thrombosis Research
·
34
A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells.
2004
·
Manabu Kawada
, Yuya Yoshimoto
, et al.
·
PubMed
·
31
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
2020
·
Yuki Tanaka
, Hiroshi Wada
, et al.
·
Scientific Reports
·
22
PDF
Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model
2003
·
Kazuhisa Minamiguchi
, Keiko T. Kitazato
, et al.
·
Kidney International
·
20
PDF
Secretive expression of the Aspergillus aculeatus cellulase (FI-CMCase) by Saccharomyces cerevisiae
1995
·
Kazuhisa Minamiguchi
, Toshihiko Ooi
, et al.
·
Journal of Fermentation and Bioengineering
·
19
Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation
2003
·
Kenji Kitazato
, Keiko T Kitazato
, et al.
·
Thrombosis Research
·
18
Expression of the Cellulase (FI-CMCase) Gene ofAspergillus aculeatusinSaccharomyces cerevisiae
1994
·
Toshihiko Ooi
, Kenji Mori
, et al.
·
Bioscience Biotechnology and Biochemistry
·
16
The Anticoagulant and Hemorrhagic Effects of DHG, a New Depolymerized Holothurian Glycosaminoglycan, on Experimental Hemodialysis in Dogs
1997
·
Kazuhisa G Minamiguchi
, Keiko T Kitazato
, et al.
·
Thrombosis and Haemostasis
·
15
Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth
2003
·
Kazuhisa Minamiguchi
, Manabu Kawada
, et al.
·
Molecular and Cellular Endocrinology
·
13
Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness
2003
·
Kazuhisa Minamiguchi
, Manabu Kawada
, et al.
·
Biochemical and Biophysical Research Communications
·
13
VAT‐1 is a novel pathogenic factor of progressive benign prostatic hyperplasia
2011
·
Fumitaka Mori
, Kiyoshi Tanigawa
, et al.
·
The Prostate
·
11
Expression of the Cellulase (FI-CMCase) Gene ofAspergillus aculeatusinEscherichia coli
1993
·
Toshihiko Ooi
, Kazuhisa Minamiguchi
, et al.
·
Bioscience Biotechnology and Biochemistry
·
10
TAS 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer
2024
·
Shohei Yoshida
, Daisuke Kajiwara
, et al.
·
Molecular Oncology
·
9
Inhibitory Activity of the Hypoxia-inducible Factor-1 Pathway by Tartrolone C
2006
·
Yohko Yamazaki
, Tetsuya Someno
, et al.
·
The Journal of Antibiotics
·
7
Interaction of a New Depolymerized Holothurian Glycosaminoglycan With Proteins in Human Plasma
1996
·
Kazuhisa Minamiguchi
, Hideki Nagase
, et al.
·
Thrombosis Research
·
7
Effect of a new type androgen receptor antagonist, TAS3681, on ligand-independent AR activation through its AR downregulation activity.
2016
·
Daisuke Kajiwara
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
6
Recombinant Alkaline Serine Protease Ii Degrades Scrapie Isoform of Prion Protein
2003
·
Zhao Hui
, Kazuhisa Minamiguchi
, et al.
·
In Vitro Cellular & Developmental Biology - Animal
·
6
TAS3681, a novel type of AR antagonist with AR downregulating activity, as a new targeted therapy for aberrant AR-driven prostate cancer.
2018
·
Masanao Seki
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
5
Analysis of novel enzalutamide-resistant cells: upregulation of testis-specific Y-encoded protein gene promotes the expression of androgen receptor splicing variant 7
2020
·
Masanao Seki
, Daisuke Kajiwara
, et al.
·
Translational Cancer Research
·
4
PDF
The impact of TAS3681, a new type of androgen receptor antagonist, on aberrant AR signaling that drives tumor resistance to AR-targeted therapies by down-regulating full length and splice variant AR.
2017
·
Daisuke Kajiwara
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
4
TAS3681: New class of androgen receptor antagonist with androgen receptor downregulating activity.
2015
·
Kazuhisa Minamiguchi
, Masanao Seki
, et al.
·
Journal of Clinical Oncology
·
3
Neutralization of DHG, a New Depolymerized Holothurian Glycosaminoglycan, by Protamine Sulfate and Platelet Factor 4
2009
·
Eiji Sasaki
, Kazuhisa Minamiguchi
, et al.
·
Haemostasis
·
2
Abstract 4437: Pimitespib (TAS-116), an HSP90 inhibitor, overcomes resistance to androgen receptor pathway inhibitors in prostate cancer by simultaneously targeting several key resistance mechanisms
2025
·
Hiromi Muraoka
, Kazuhisa Minamiguchi
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
37
Citation count:
453
H-index:
12
I10-index:
14
Year
Topic
Type
